Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:CNBS NASDAQ:EMXF NYSEARCA:IDNA NASDAQ:LEGR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCNBSAmplify Seymour Cannabis ETF$30.60+5.5%$18.90$13.96▼$57.93$111.38M1.6235,876 shs23,168 shsEMXFiShares ESG Advanced MSCI EM ETF$43.69-0.3%$43.02$34.03▼$44.33$109.23M0.636,808 shs2,551 shsIDNAiShares Genomics Immunology and Healthcare ETF$22.54+0.1%$21.38$17.26▼$25.80$116.08M0.929,968 shs6,847 shsLEGRFirst Trust Indxx Innovative Transaction & Process ETF$54.51-0.2%$53.75$41.87▼$54.97$106.29M0.976,597 shs8,994 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCNBSAmplify Seymour Cannabis ETF+7.05%-9.46%+63.75%+73.44%-95.52%EMXFiShares ESG Advanced MSCI EM ETF-0.14%-1.15%+0.27%+7.53%+14.82%IDNAiShares Genomics Immunology and Healthcare ETF-0.13%+0.22%+5.68%+11.60%-9.05%LEGRFirst Trust Indxx Innovative Transaction & Process ETF+0.02%-0.33%+0.93%+5.68%+21.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCNBSAmplify Seymour Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/AEMXFiShares ESG Advanced MSCI EM ETFN/AN/AN/AN/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AN/AN/AN/AN/AN/AN/AN/ALEGRFirst Trust Indxx Innovative Transaction & Process ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCNBSAmplify Seymour Cannabis ETF 2.59Moderate Buy$30.60N/AEMXFiShares ESG Advanced MSCI EM ETF 2.80Moderate Buy$43.720.05% UpsideIDNAiShares Genomics Immunology and Healthcare ETF 2.68Moderate Buy$22.54N/ALEGRFirst Trust Indxx Innovative Transaction & Process ETF 2.78Moderate Buy$54.51N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCNBSAmplify Seymour Cannabis ETFN/AN/AN/AN/AN/AN/AEMXFiShares ESG Advanced MSCI EM ETFN/AN/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AN/AN/AN/AN/AN/ALEGRFirst Trust Indxx Innovative Transaction & Process ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCNBSAmplify Seymour Cannabis ETFN/AN/A17.73∞N/AN/AN/AN/AN/AEMXFiShares ESG Advanced MSCI EM ETFN/AN/A13.05∞N/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AN/A14.76∞N/AN/AN/AN/AN/ALEGRFirst Trust Indxx Innovative Transaction & Process ETFN/AN/A14.62∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCNBSAmplify Seymour Cannabis ETF$10.7135.00%N/AN/AN/AEMXFiShares ESG Advanced MSCI EM ETF$1.313.00%N/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETF$0.261.15%N/AN/AN/ALEGRFirst Trust Indxx Innovative Transaction & Process ETF$1.162.13%N/AN/AN/ALatest CNBS, LEGR, IDNA, and EMXF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/25/2025LEGRFirst Trust Indxx Innovative Transaction & Process ETFQuarterly$0.55794.19%6/26/20256/26/20256/30/20256/13/2025EMXFiShares ESG Advanced MSCI EM ETF$0.53096/16/20256/16/20256/20/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCNBSAmplify Seymour Cannabis ETFN/AEMXFiShares ESG Advanced MSCI EM ETFN/AIDNAiShares Genomics Immunology and Healthcare ETFN/ALEGRFirst Trust Indxx Innovative Transaction & Process ETFN/AInsider OwnershipCompanyInsider OwnershipCNBSAmplify Seymour Cannabis ETFN/AEMXFiShares ESG Advanced MSCI EM ETFN/AIDNAiShares Genomics Immunology and Healthcare ETFN/ALEGRFirst Trust Indxx Innovative Transaction & Process ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCNBSAmplify Seymour Cannabis ETFN/A3.64 millionN/ANot OptionableEMXFiShares ESG Advanced MSCI EM ETFN/A2.50 millionN/ANot OptionableIDNAiShares Genomics Immunology and Healthcare ETFN/A5.15 millionN/ANot OptionableLEGRFirst Trust Indxx Innovative Transaction & Process ETF147,0001.95 millionN/AOptionableCNBS, LEGR, IDNA, and EMXF HeadlinesRecent News About These CompaniesFirst Trust Indxx Innovative Transaction & Process ETFJune 26, 2025 | benzinga.comFirst Trust Indxx Innovative Transaction & Process ETF declares $0.125 dividendMarch 28, 2025 | seekingalpha.comFirst Trust Indxx Innovative Tr (LEGR) stock forecast and price targetFebruary 2, 2025 | ca.finance.yahoo.comFirst Look At The LEGR ETF Results In A Strong Sell RatingJanuary 5, 2025 | seekingalpha.comFirst Trust rolls out aerospace and semiconductor ETFsDecember 12, 2024 | portfolio-adviser.comP(LEGR) Trading SignalsNovember 2, 2024 | news.stocktradersdaily.comNHow to Take Advantage of moves in (LEGR)October 23, 2024 | news.stocktradersdaily.comNFirst Trust Indxx Global Natural Resources Income ETF (NASDAQ:FTRI), Short Interest ReportOctober 22, 2024 | benzinga.com(LEGR) Investment ReportOctober 2, 2024 | news.stocktradersdaily.comN(LEGR) Trading ReportSeptember 5, 2024 | news.stocktradersdaily.comNFirst Trust Indxx Innovative Transaction & Process UCITS ETF (BLOK)August 3, 2024 | fidelity.co.ukFXACVX Virtus Diversified Income & Convertible FundJuly 19, 2024 | seekingalpha.comFirst Trust Indxx Fut Eco Mtls Ucits Etf Share ChatApril 24, 2024 | lse.co.ukStop! Skip the Bitcoin ETFs and Buy These 3 Funds Instead.February 26, 2024 | investorplace.comFirst Trust Indxx Metaverse ETF (ARVR)December 22, 2023 | investing.comFirst Trust Indxx Metaverse ETFNovember 16, 2023 | thestreet.comFirst Trust Indxx Metaverse ETFNovember 16, 2023 | thestreet.comFirst Trust Large Cap Growth AlphaDEX® Fund declares quarterly distribution of $0.1326June 27, 2023 | msn.comFirst Trust Indxx Innovative Transaction & Process ETF declares quarterly distribution of $0.4796June 27, 2023 | msn.comClosing Bell: First Trust Indxx Innov Trans Proc ETF up on Wednesday (BLCK)April 9, 2023 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCNBS, LEGR, IDNA, and EMXF Company DescriptionsAmplify Seymour Cannabis ETF NYSEARCA:CNBS$30.60 +1.60 (+5.52%) Closing price 04:10 PM EasternExtended Trading$29.74 -0.86 (-2.81%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Amplify Growth Opportunities ETF (CNBS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global stocks related to cannabis and hemp. The fund also invests in derivatives with similar characteristics. CNBS was launched on Jul 23, 2019 and is managed by Amplify.iShares ESG Advanced MSCI EM ETF NASDAQ:EMXF$43.69 -0.13 (-0.29%) Closing price 03:54 PM EasternExtended Trading$43.69 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The iShares ESG Advanced MSCI EM ETF (EMXF) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a market cap-weighted index of large- and mid-cap equities in emerging markets, screened for positive ESG rating while also screening for involvement in controversial activities. EMXF was launched on Oct 6, 2020 and is managed by BlackRock.iShares Genomics Immunology and Healthcare ETF NYSEARCA:IDNA$22.54 +0.02 (+0.09%) Closing price 04:10 PM EasternExtended Trading$22.56 +0.03 (+0.11%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.First Trust Indxx Innovative Transaction & Process ETF NASDAQ:LEGR$54.51 -0.09 (-0.17%) Closing price 03:57 PM EasternExtended Trading$54.51 +0.00 (+0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The First Trust Indxx Innovative Transaction & Process ETF (LEGR) is an exchange-traded fund that is based on the Indxx Blockchain index. The fund tracks an index of global equities selected based on their exposure to the development or usage of blockchain technology. LEGR was launched on Jan 24, 2018 and is managed by First Trust. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Palantir is Selling Off, BigBear.ai Could Be Your Hedge ASML Has Entered Buy Territory, But Only For Patient Investors Lowe’s Builds Value for Investors: Still a Good Buy in 2025 Target: Missing the Mark in 2025—Downtrend May Continue Toll Brothers: A Great Buy and Hold Stock With Risks in 2025 Amazon Stock Sets Up for Breakout After Bullish Crossover Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access